Prelude Capital Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,054
| Closed | -$73.4K | – | 1288 |
|
|
2024
Q4 | $73.4K | Sell |
2,054
-12,535
| -86% | -$448K | ﹤0.01% | 996 |
|
|
2024
Q3 | $689K | Buy |
+14,589
| New | +$689K | 0.04% | 443 |
|
|
2020
Q4 | – | Sell |
-18
| Closed | -$8K | – | 1266 |
|
|
2020
Q3 | $8K | Buy |
+18
| New | +$8K | ﹤0.01% | 1120 |
|
|
2018
Q2 | – | Sell |
-90
| Closed | -$36K | – | 1546 |
|
|
2018
Q1 | $36K | Buy |
90
+86
| +2,150% | +$34.4K | ﹤0.01% | 1019 |
|
|
2017
Q4 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 1162 |
|